{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-18T12:23:00.839588+00:00",
  "news": [
    {
      "title": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-01-12T23:45:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T15:23:57+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company - Yahoo Finance UK",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNal9tNG5KNmt4UzJ2Ynh0azlyVnRVZkpuZWkwam9pTFRxaGRTbG1FdUlKWkRtc3FKbXpISEJhMk1kcGw0LUwyajdNSUZOd09BNDRCQ2VWNF9xZlI0cVc0X1JWVFI4c3FqS1VlU0Q2UXB5TEtFUGFnTnF2WFpiN0hwYlZFUFo?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxNal9tNG5KNmt4UzJ2Ynh0azlyVnRVZkpuZWkwam9pTFRxaGRTbG1FdUlKWkRtc3FKbXpISEJhMk1kcGw0LUwyajdNSUZOd09BNDRCQ2VWNF9xZlI0cVc0X1JWVFI4c3FqS1VlU0Q2UXB5TEtFUGFnTnF2WFpiN0hwYlZFUFo?oc=5\" target=\"_blank\">Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance UK</font>",
      "published": "2026-01-18T12:00:26+00:00",
      "source": "Yahoo Finance UK"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T23:46:17+00:00",
      "source": "CNBC"
    },
    {
      "title": "JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data - Clinical Trials Arena",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ2xLZDRlUHRpLUhsSTlWWHcwU1p3NnNZN3NhbUlmZmFtVVFmWlVoNGlCMGV6Uk53RnYxMmxXMnVPaHlTMjhMNThKVHdiOTlKdm9kcW1TZk1xSTYtblRuTnlsd0Z3N1FOeDVqT1RVb1ZqQVBzWXNuZUtFQWJsTldpUnpWXzBNVDBGLXJ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ2xLZDRlUHRpLUhsSTlWWHcwU1p3NnNZN3NhbUlmZmFtVVFmWlVoNGlCMGV6Uk53RnYxMmxXMnVPaHlTMjhMNThKVHdiOTlKdm9kcW1TZk1xSTYtblRuTnlsd0Z3N1FOeDVqT1RVb1ZqQVBzWXNuZUtFQWJsTldpUnpWXzBNVDBGLXJ3?oc=5\" target=\"_blank\">JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Clinical Trials Arena</font>",
      "published": "2026-01-14T12:22:30+00:00",
      "source": "Clinical Trials Arena"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5\" target=\"_blank\">Amgen buys protein-degrading startup Dark Blue for up to $840M</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Amgen dances with Disco in $618M cancer target pact - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5\" target=\"_blank\">Amgen dances with Disco in $618M cancer target pact</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-07T08:00:00+00:00",
      "source": "Fierce Biotech"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-16",
      "close": 330.4100036621094
    },
    "history": [
      {
        "date": "2026-01-08",
        "close": 330.1099853515625
      },
      {
        "date": "2026-01-09",
        "close": 326.1000061035156
      },
      {
        "date": "2026-01-12",
        "close": 325.5400085449219
      },
      {
        "date": "2026-01-13",
        "close": 324.29998779296875
      },
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      },
      {
        "date": "2026-01-15",
        "close": 330.0299987792969
      },
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      }
    ],
    "name": "Amgen Inc."
  }
}